FGFR-Related Skeletal Dysplasias and Craniosynostosis Syndromes

name: FGFR-Related Skeletal Dysplasias
display_name: FGFR-Related Skeletal Dysplasias and Craniosynostosis Syndromes
creation_date: "2026-06-13T00:00:00Z"
description: >-
  A group of Mendelian skeletal disorders caused by gain-of-function variants in
  the fibroblast growth factor receptor genes FGFR1, FGFR2, and FGFR3.
  Constitutive receptor activation drives sustained MAPK/STAT signaling that is
  read out in two skeletal compartments: in the cartilaginous growth plate it
  dysregulates chondrocyte proliferation and endochondral ossification (the
  short-limb chondrodysplasias, predominantly FGFR3), and at the cranial sutures
  it accelerates osteogenic differentiation and premature suture fusion (the
  craniosynostosis syndromes, predominantly FGFR1/FGFR2). The same pathway
  produces a severity gradient from mild (hypochondroplasia) to perinatally
  lethal (thanatophoric dysplasia).
grouping_basis:
- SHARED_GENE_FAMILY
- SHARED_MECHANISM
grouping_rationale: >-
  Grouped on a shared gene family and mechanism: each member conforms to the
  fgfr_gain_of_function_skeletal_dysplasia module (constitutive FGFR activation
  -> sustained MAPK/STAT signaling -> growth-plate and/or cranial-suture
  dysregulation). Members are kept as separate Disease entries because they
  differ in the causal receptor paralog (FGFR1/2/3), the specific activating
  variant and its strength, and which skeletal compartment dominates
  (endochondral chondrodysplasia vs craniosynostosis). The criteria are
  NECESSARY_AND_SUFFICIENT: conforming to the FGFR module both characterizes
  every member and identifies any other FGFR-driven skeletal disorder as a
  candidate member.
membership_criteria:
- description: >-
    A disorder is an FGFR-related skeletal dysplasia if and only if it conforms
    to the FGFR gain-of-function skeletal dysplasia module (a constitutively
    activating FGFR variant driving growth-plate or cranial-suture
    dysregulation).
  criteria_semantics: NECESSARY_AND_SUFFICIENT
  logic:
    criterion_predicate: CONFORMS_TO_MODULE
    module: fgfr_gain_of_function_skeletal_dysplasia#Constitutive FGFR Activation
    description: >-
      Conforms to the FGFR module's constitutive receptor-activation node.
members:
- member: Achondroplasia
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      The prototypical FGFR3 chondrodysplasia: the recurrent p.Gly380Arg variant
      causes rhizomelic short stature, macrocephaly, and trident hands — the
      reference point of the FGFR3 short-limb severity gradient.
    gene:
      preferred_term: FGFR3
      term:
        id: hgnc:3690
        label: FGFR3
- member: Hypochondroplasia
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      Milder FGFR3 activation (commonly p.Asn540Lys) producing disproportionate
      short stature without the craniofacial features of achondroplasia — the
      mild end of the FGFR3 gradient.
    gene:
      preferred_term: FGFR3
      term:
        id: hgnc:3690
        label: FGFR3
- member: Thanatophoric Dysplasia
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      The TD-level root entry, listed alongside its two subtype entries rather
      than instead of them: it carries only what is reported for thanatophoric
      dysplasia as a whole — the TD birth prevalence, the shared
      ultrasound-to-radiograph-to-molecular diagnostic pathway (one FGFR3 assay
      covers both subtypes), and the thoracic-insufficiency step that makes the
      disorder perinatally lethal — while the allele-specific detail sits in the
      Type 1 and Type 2 members. It is a member in its own right because it
      independently conforms to the module's constitutive-activation and
      endochondral-ossification nodes.
    gene:
      preferred_term: FGFR3
      term:
        id: hgnc:3690
        label: FGFR3
- member: Thanatophoric Dysplasia Type 1
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      Strong FGFR3 activation producing perinatally lethal short-limb dwarfism
      with curved ("telephone receiver") femurs and a narrow thorax — the severe
      end of the gradient.
    gene:
      preferred_term: FGFR3
      term:
        id: hgnc:3690
        label: FGFR3
- member: Thanatophoric Dysplasia Type 2
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      The recurrent FGFR3 p.Lys650Glu variant produces lethal dwarfism with
      straight femurs and cloverleaf skull, distinguishing it from type 1.
    gene:
      preferred_term: FGFR3
      term:
        id: hgnc:3690
        label: FGFR3
- member: SADDAN
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      Severe achondroplasia with developmental delay and acanthosis nigricans;
      the FGFR3 p.Lys650Met variant gives a survivable phenotype more severe than
      achondroplasia, bridging to thanatophoric dysplasia.
    gene:
      preferred_term: FGFR3
      term:
        id: hgnc:3690
        label: FGFR3
- member: Crouzon Syndrome with Acanthosis Nigricans
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      An FGFR3 craniosynostosis (recurrent p.Ala391Glu) — unusual in that an
      FGFR3 variant produces a craniosynostosis rather than a chondrodysplasia,
      combined with acanthosis nigricans.
    gene:
      preferred_term: FGFR3
      term:
        id: hgnc:3690
        label: FGFR3
- member: Muenke Syndrome
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      The single recurrent FGFR3 p.Pro250Arg variant causes coronal
      craniosynostosis with variable penetrance — an FGFR3 suture phenotype
      distinct from its chondrodysplasia phenotypes.
    gene:
      preferred_term: FGFR3
      term:
        id: hgnc:3690
        label: FGFR3
- member: Apert Syndrome
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      FGFR2 activation (p.Ser252Trp / p.Pro253Arg) producing bicoronal
      craniosynostosis with severe symmetric syndactyly of hands and feet — the
      most severe of the FGFR2 craniosynostoses.
    gene:
      preferred_term: FGFR2
      term:
        id: hgnc:3689
        label: FGFR2
- member: Crouzon Syndrome
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      FGFR2 craniosynostosis with midface hypoplasia and proptosis but normal
      hands and feet, distinguishing it from Apert and Pfeiffer.
    gene:
      preferred_term: FGFR2
      term:
        id: hgnc:3689
        label: FGFR2
- member: Pfeiffer Syndrome
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      Craniosynostosis with broad, medially deviated thumbs and great toes;
      caused by FGFR1 (p.Pro252Arg) or FGFR2 variants — the FGFR1 paralog member
      of the group.
    gene:
      preferred_term: FGFR1
      term:
        id: hgnc:3688
        label: FGFR1
- member: Jackson-Weiss Syndrome
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      FGFR2 craniosynostosis with characteristic foot anomalies (broad great
      toes, tarsal/metatarsal fusion) but normal hands.
    gene:
      preferred_term: FGFR2
      term:
        id: hgnc:3689
        label: FGFR2
- member: Beare-Stevenson Cutis Gyrata Syndrome
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      The member that joins the group's two arms at the level of receptor activation
      rather than tissue. Its recurrent alleles — FGFR2 p.Tyr375Cys in the transmembrane
      domain and p.Ser372Cys in the Ig-III/transmembrane linker — are cysteine-creating
      substitutions that drive ligand-independent, disulfide-mediated dimerization, the
      same activation class as the extracellular-cysteine alleles of thanatophoric
      dysplasia type 1 on the FGFR3 chondrodysplasia side, and mechanistically unlike the
      ligand-affinity linker alleles of Apert and Muenke. Clinically it is set apart by a
      skin arm no other FGFR2 craniosynostosis has — cutis gyrata with acanthosis
      nigricans and skin tags, driven through p38 MAPK — and by markedly higher mortality
      than Apert, Pfeiffer or Crouzon syndrome, with a tracheal cartilaginous sleeve the
      leading candidate cause of its excess sudden death.
    gene:
      preferred_term: FGFR2
      term:
        id: hgnc:3689
        label: FGFR2
    module: fgfr_gain_of_function_skeletal_dysplasia#Constitutive FGFR Activation
- member: Antley-Bixler Syndrome, FGFR2-Related
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      The only member that fuses a limb joint as well as the cranial sutures: synostosis
      of cranial sutures AND elbow joints were the syndrome's original minimal diagnostic
      criteria, so the same receptor lesion is read out at a developing appendicular joint
      rather than only at the skull. Its recurrent FGFR2 p.Ser351Cys is a cysteine-creating
      IgIII-domain substitution, the ligand-independent disulfide-dimerization activation
      class it shares with Beare-Stevenson. Two cautions travel with this member and are
      curated in the entry: the syndrome name also denotes an unrelated autosomal
      recessive POR steroidogenesis disorder (MONDO:0008726) that dominates the
      literature, and whether the FGFR2 form is a distinct entity rather than a severe
      variant of the FGFR2 craniosynostosis syndromes is itself disputed. Neither caution
      touches the mechanism, which is why membership is unaffected.
    gene:
      preferred_term: FGFR2
      term:
        id: hgnc:3689
        label: FGFR2
    module: fgfr_gain_of_function_skeletal_dysplasia#Constitutive FGFR Activation
- member: Osteoglophonic Dysplasia
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      The only member in which one activating FGFR allele produces both arms of
      the group at once: FGFR1 gain of function (a small recurrent allelic series
      including p.Cys381Arg) gives multisuture craniosynostosis *and* rhizomelic
      short stature, rather than one compartment dominating. It adds two features
      no other member has — nonossifying metaphyseal fibrous lesions ("hollowed-out
      bone"), which can behave as aggressive recurrent central giant cell
      granulomas, and an endocrine arm of FGF23 excess with renal phosphate
      wasting and hypophosphatemia. It is allelic to Pfeiffer syndrome and is
      repeatedly misdiagnosed as it.
    gene:
      preferred_term: FGFR1
      term:
        id: hgnc:3688
        label: FGFR1
notes: >-
  Internally organized into two arms: an FGFR3 short-limb chondrodysplasia arm
  (achondroplasia -> hypochondroplasia -> SADDAN -> thanatophoric dysplasia
  severity gradient) and an FGFR1/FGFR2 craniosynostosis arm, with FGFR3
  contributing the unusual Crouzon-with-acanthosis-nigricans and Muenke suture
  phenotypes. Osteoglophonic dysplasia (FGFR1) sits across both arms and is the
  group's only member with an endocrine (FGF23/phosphate-wasting) component.

  The arms are anatomical, not mechanistic, and one member makes that explicit.
  Beare-Stevenson syndrome is a craniosynostosis by phenotype but a cysteine-allele
  disorder by activation mechanism, sharing ligand-independent disulfide-mediated
  dimerization with thanatophoric dysplasia type 1 in the opposite arm. Read across
  the group, activation mechanism (cysteine-creating versus ligand-affinity linker
  versus kinase-domain) and affected compartment (growth plate versus suture) vary
  independently — which is what the module's fgfr_activation_mechanism_heterogeneity
  hypothesis asserts, and why a severity gradient is curated only within the FGFR3
  chondrodysplasia arm.

  Thanatophoric dysplasia is listed at two levels on purpose. The TD root entry
  and its Type 1 / Type 2 entries are three separate curated Disease entries, and
  all three independently satisfy the NECESSARY_AND_SUFFICIENT criterion, so all
  three are listed. Membership here is a union over curated entries, not a
  partition: listing the root does not make the subtypes redundant, and omitting
  it would leave the audit reporting a permanent unexplained candidate.

  Deliberate non-members. Three curated FGFR entries are excluded on mechanism,
  not oversight: Hartsfield syndrome (FGFR1 dominant-negative/loss of function,
  not gain), FGFR1-related hypogonadotropic hypogonadism and Kallmann syndrome
  (FGFR1 loss of function), and encephalocraniocutaneous lipomatosis (mosaic
  FGFR1 gain of function, but a neurocutaneous rather than skeletal-dysplasia
  phenotype). Wolf-Hirschhorn syndrome carries FGFR3 in its 4p16.3 deletion
  interval but is a contiguous-gene deletion, the opposite of the group's
  gain-of-function mechanism.

  Correction, 2026-08-22. This note previously listed three unfilled seats. All
  three are now resolved, in two directions. Beare-Stevenson cutis gyrata syndrome
  was curated and added as a member (#9257), as was the FGFR2 form of
  Antley-Bixler syndrome (#9404). Bent bone dysplasia syndrome was curated (#9384)
  and turns out NOT to belong: it was listed here on the assumption that an FGFR2
  skeletal dysplasia with craniosynostosis must be a receptor gain-of-function
  disorder, and that assumption was wrong. Its transmembrane alleles reduce
  plasma-membrane FGFR2 and diminish FGF responsiveness (PMID:22387015, titled
  "…has deficient canonical FGF signaling"); what is gained is nucleolar
  relocalization of the receptor to the rDNA promoter, not receptor activity
  (PMID:24908667). It therefore fails this grouping's criterion and is
  deliberately excluded, alongside the other deliberate non-members above. See
  kb/disorders/FGFR2-Related_Bent_Bone_Dysplasia.yaml.

  So no unfilled seats remain. That does not mean the group is closed — a newly
  described FGFR gain-of-function skeletal disorder would qualify — only that
  nothing currently known to us is waiting.

  The general lesson is worth keeping: within this group, allele position does not
  settle membership. Bent bone dysplasia's alleles sit in the same transmembrane
  domain as achondroplasia p.Gly380Arg and Beare-Stevenson p.Tyr375Cys, and FGFR2
  Tyr-381 substitutions have been reported to give either Crouzon syndrome or bent
  bone dysplasia depending on the substituting residue. Membership is a claim
  about receptor behaviour and has to be checked against functional evidence, not
  inferred from the gene, the domain, or the presence of craniosynostosis.

  MONDO mapping: deliberately omitted. No single MONDO class corresponds to this
  FGFR gene-family grouping — MONDO splits the members across osteochondrodysplasia
  (FGFR3 chondrodysplasias) and craniosynostosis (FGFR1/2), with no
  "FGFR-related skeletal dysplasia" parent. The grouping is defined by shared
  receptor gene/mechanism, which crosscuts the MONDO anatomical taxonomy; the
  MONDO-descendant prioritization tool therefore does not apply to it.